Literature DB >> 24231690

Undifferentiated uterine sarcoma metastatic to the brain.

Douglas L Stofko1.   

Abstract

BACKGROUND: Undifferentiated uterine sarcoma (UUS) is a rare tumor with an aggressive growth pattern. They occur in women from 40 to 60 years and are generally characterized by poor prognosis, a high rate of local recurrence, and distant metastases. UUS accounts for 0.2% of all gynecological malignancies. Possible treatments include surgery, radiotherapy, and chemotherapy. CASE DESCRIPTION: A 65-year-old female with postmenopausal bleeding was found to have a uterine mass for which she underwent a total abdominal hysterectomy, bilateral salpingo-oophorectomy, and omentectomy. The pathologic evaluation was consistent with undifferentiated endometrial sarcoma. She began experiencing headaches with associated visual disturbances. Magnetic resonance imaging (MRI) of the brain showed a homogenous enhancing occipital dural-based mass measuring 1.6 × 1.8 × 1.7 cm. Due to the rarity of metastatic uterine sarcoma to the brain, this was believed to represent a meningioma and subsequently observed. Interval MRI scan revealed a significant increase in size of the right occipital mass to 2.3 cm with increased edema and mass effect. She underwent right occipital image guided craniotomy for resection of the mass. Histopathology confirmed UUS metastases.
CONCLUSION: Randomized trials analyzing these treatment options are limited due to the rarity of this disease; therefore, a standard therapy is not established. Based on a review of the literature, this is only the fourth case reported of UUS metastatic to the brain.

Entities:  

Keywords:  Brain metastases; endometrial stromal sarcoma; undifferentiated uterine sarcoma; uterine sarcoma

Year:  2013        PMID: 24231690      PMCID: PMC3815079          DOI: 10.4103/2152-7806.119054

Source DB:  PubMed          Journal:  Surg Neurol Int        ISSN: 2152-7806


  17 in total

1.  Uterine leiomyosarcoma: analysis of treatment failures and survival.

Authors:  A Gadducci; F Landoni; E Sartori; P Zola; T Maggino; A Lissoni; L Bazzurini; R Arisio; C Romagnolo; R Cristofani
Journal:  Gynecol Oncol       Date:  1996-07       Impact factor: 5.482

2.  Patterns of metastasis in uterine sarcoma. An autopsy study.

Authors:  P G Rose; M S Piver; Y Tsukada; T Lau
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

3.  Uterine leiomyosarcoma metastasis to the skull--case report.

Authors:  M Uchino; G Endo; I Shibata; H Terao; T Kuramitsu; Y Kushida; N Nakamura
Journal:  Neurol Med Chir (Tokyo)       Date:  1996-07       Impact factor: 1.742

4.  Leiomyosarcoma metastatic to the brain with prolonged survival.

Authors:  J Vaquero; R Martínez; A el Barkani; J C Gómez-Angulo; J Escandón
Journal:  J Neurosurg Sci       Date:  1989 Jul-Sep       Impact factor: 2.279

5.  Autopsy findings in patients with uterine sarcoma.

Authors:  W P Fleming; W A Peters; N B Kumar; G W Morley
Journal:  Gynecol Oncol       Date:  1984-10       Impact factor: 5.482

6.  Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence.

Authors:  B A Goff; L W Rice; D Fleischhacker; H G Muntz; S S Falkenberry; N Nikrui; A F Fuller
Journal:  Gynecol Oncol       Date:  1993-07       Impact factor: 5.482

7.  Increased incidence of brain metastases in sarcoma patients.

Authors:  P España; P Chang; P H Wiernik
Journal:  Cancer       Date:  1980-01-15       Impact factor: 6.860

8.  Uterine leiomyosarcoma with intracerebral metastasis: a case report.

Authors:  P R Prussia; H A Clarke; G Mansoor; S Garriques; B Maheswaran
Journal:  J Natl Med Assoc       Date:  1992-04       Impact factor: 1.798

Review 9.  Leiomyosarcoma of the uterus metastatic to brain: a case report and a review of the literature.

Authors:  M Wroński; P de Palma; E Arbit
Journal:  Gynecol Oncol       Date:  1994-08       Impact factor: 5.482

Review 10.  Treatment of early uterine sarcomas: disentangling adjuvant modalities.

Authors:  Flora Zagouri; Athanasios-Meletios Dimopoulos; Stelios Fotiou; Vassilios Kouloulias; Christos A Papadimitriou
Journal:  World J Surg Oncol       Date:  2009-04-08       Impact factor: 2.754

View more
  1 in total

1.  Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?

Authors:  Laura Gonzalez Dos Anjos; Bruna Cristine de Almeida; Thais Gomes de Almeida; André Mourão Lavorato Rocha; Giovana De Nardo Maffazioli; Fernando Augusto Soares; Isabela Werneck da Cunha; Edmund Chada Baracat; Katia Candido Carvalho
Journal:  Cancers (Basel)       Date:  2018-09-06       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.